Annual Cash & Cash Equivalents
$35.14 M
-$9.30 M-20.93%
December 31, 2023
Summary
- As of February 6, 2025, LENZ annual cash & cash equivalents is $35.14 million, with the most recent change of -$9.30 million (-20.93%) on December 31, 2023.
- During the last 3 years, LENZ annual cash & cash equivalents has risen by +$16.83 million (+91.95%).
- LENZ annual cash & cash equivalents is now -20.93% below its all-time high of $44.44 million, reached on December 31, 2022.
Performance
LENZ Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$41.05 M
-$42.99 M-51.16%
September 30, 2024
Summary
- As of February 6, 2025, LENZ quarterly cash and cash equivalents is $41.05 million, with the most recent change of -$42.99 million (-51.16%) on September 30, 2024.
- Over the past year, LENZ quarterly cash and cash equivalents has dropped by -$1.80 million (-4.21%).
- LENZ quarterly cash and cash equivalents is now -79.51% below its all-time high of $200.36 million, reached on March 31, 2024.
Performance
LENZ Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LENZ Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -4.2% |
| 3 y3 years | +92.0% | - |
| 5 y5 years | +92.0% | - |
LENZ Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.9% | +92.0% | -79.5% | +16.8% |
| 5 y | 5-year | -20.9% | +92.0% | -79.5% | +16.8% |
| alltime | all time | -20.9% | +92.0% | -79.5% | +16.8% |
LENZ Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $41.05 M(-51.2%) |
| Jun 2024 | - | $84.03 M(-58.1%) |
| Mar 2024 | - | $200.36 M(+470.2%) |
| Dec 2023 | $35.14 M | $35.14 M(-18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $42.85 M(-3.6%) |
| Dec 2022 | $44.44 M(+142.8%) | - |
| Dec 2022 | - | $44.44 M |
| Dec 2021 | $18.31 M | - |
FAQ
- What is LENZ Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LENZ Therapeutics?
- What is LENZ Therapeutics annual cash & cash equivalents year-on-year change?
- What is LENZ Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for LENZ Therapeutics?
- What is LENZ Therapeutics quarterly cash and cash equivalents year-on-year change?
What is LENZ Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of LENZ is $35.14 M
What is the all time high annual cash & cash equivalents for LENZ Therapeutics?
LENZ Therapeutics all-time high annual cash & cash equivalents is $44.44 M
What is LENZ Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, LENZ annual cash & cash equivalents has changed by -$9.30 M (-20.93%)
What is LENZ Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LENZ is $41.05 M
What is the all time high quarterly cash and cash equivalents for LENZ Therapeutics?
LENZ Therapeutics all-time high quarterly cash and cash equivalents is $200.36 M
What is LENZ Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, LENZ quarterly cash and cash equivalents has changed by -$1.80 M (-4.21%)